CAS No. 1291094-73-9

Description:
LIK066 is a potent sodium-glucose transporter 1 and sodium-glucose transporter 2 inhibitor originated by Novartis Pharmaceuticals Corporation IC50 with value of 22.0 nM against human SGLT1 and 0.5 nM against human SGLT2. In Apr 2016, Novartis completed a phase II trial for Type 2 diabetes mellitus in USA.

• Molecular Weight: 948.07
• Molecular Formula: C51H65NO16

Purity: 98%

Canonical SMILES:
CCC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC4=C(C=C3)OCCO4

InChI:
InChI=1S/C23H28O7/c1-2-14-4-5-15(23-22(27)21(26)20(25)19(12-24)30-23)11-16(14)9-13-3-6-17-18(10-13)29-8-7-28-17/h3-6,10-11,19-27H,2,7-9,12H2,1H3/t19-,20-,21+,22-,23+/m1/s1

InChIKey: XFJAMQQAAMJFGB-ZQGJOIPISA-N

• Solubility: Soluble in DMSO
• Appearance: Powder
• Application: Type 2 diabetes mellitus
• Storage: -20°C Freezer

Synonyms:
LIK-066; LIK 066; licogliflozin

More details are to be found on supplier website

Smile code:
O[C@H]1[C@H](C2=CC(CC3=CC=C4C(OCCO4)=C3)=C(CC)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O
MDL Number:
MFCD31630771
Purity :
98+%
Available in stock:
10.79 g